sustain 6 trial semaglutide Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous in the treatment of type 2 diabetes: Insights from the 1–7 trials SELECT Trial

This genetic insight helps optimize your treatment plan and predict which GLP-1 approachinjection or oralmay work best for your unique biology

The honest answer is probably yes, with the right oversight, the right titration, and a plan that doesn't assume the drug does all the work

Liver disease

Although this is an attractive approach that spurred great interest, caution should be exercised as standard dosing may be a challenge depending on individual inhalation technique

These side effects are usually mild and go away on their own, but some people may need to adjust their dose or switch to a different medication

Semaglutide injection has been approved by the FDA for chronic weight management in adults who are obese or overweight and have at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), in addition to a reduced-calorie diet and increased physical activity